Alnylam Pharmaceuticals (ALNY) Price to Sales (2010 - 2026)
Alnylam Pharmaceuticals' Price to Sales was 8.38 in Q2 2026, down 62.8% from 22.51 a year earlier and down 18.6% from the prior quarter.
Analysis
Alnylam Pharmaceuticals (ALNY) Price to Sales (2010 - 2026) Analysis & Trends
For FY2025, Price to Sales at Alnylam Pharmaceuticals came in at 14.17, up 4.7% from FY2024.
- In earlier years, Price to Sales was 13.53 in FY2024 (+2.8%), 13.17 in FY2023 (-53.6%), 28.39 in FY2022 (+17.6%) and 24.14 in FY2021 (-21.4%).
- The Q2 2026 figure marks the lowest quarterly Price to Sales since Q2 2012.
- Compared with a year earlier, Price to Sales was higher in six of the last eight quarters, with growth averaging 20.0%.
- The best year-over-year quarter for Price to Sales over five years was Q1 2025 (growth of 109.1%); the worst was Q2 2026 (a decline of 62.8%).
- Per Business Quant data, ALNY's Price to Sales in the three quarters before Q2 2026 was 10.30 (Q1 2026), 16.71 (Q4 2025) and 22.71 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Alnylam Pharmaceuticals | 29.38 Bn | 17.43 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.38 |
| Mar 31, 2026 | 10.30 |
| Dec 31, 2025 | 14.18 |
| Sep 30, 2025 | 19.28 |
| Jun 30, 2025 | 16.90 |
| Dec 31, 2024 | 13.53 |
| Sep 30, 2024 | 16.92 |
| Jun 30, 2024 | 13.27 |
| Mar 31, 2024 | 9.43 |
| Dec 31, 2023 | 13.17 |
| Sep 30, 2023 | 12.89 |
| Jun 30, 2023 | 19.17 |
| Mar 31, 2023 | 21.77 |
| Dec 31, 2022 | 28.39 |
| Sep 30, 2022 | 25.62 |
| Jun 30, 2022 | 19.96 |
| Mar 31, 2022 | 22.40 |
| Dec 31, 2021 | 24.14 |
| Sep 30, 2021 | 30.11 |
| Jun 30, 2021 | 29.24 |
API Access
Alnylam Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();